For Health Care Professional Use Only      
Choosing a pump is
an important
decision -
know the facts
System Features Why It’s Important MiniMed® Veo™ Integrated System OmniPod® Insulin
Management System
Insulin Pump with Integrated Continuous Glucose Monitoring (CGM) CGM on the pump has been shown to help improve clinical outcomes with both reductions in hypoglycemia and A1c.2,14 Integrated with the enhanced Enlite® Glucose Sensor. CGM data is visible on the screen of the pump, providing real-time readings & long-term trend tracking. A Medtronic CGM starter kit is included at no additional charge. NO Integrated CGM is not available.
Low Glucose Suspend (LGS) A diabetes management tool that is clinically proven to help reduce lows.7,15 The only pump available with this feature. Automatically stops insulin delivery when sensor glucose values reach a preset low glucose level and patient does not respond to the Low Glucose Suspend alarm. LGS increases patients’ confidence to achieve better control.3 NO
Active Insulin Tracking In order to safely calculate boluses and avoid “insulin stacking”, a pump should track all active insulin in the body. Tracks all active insulin from food and correction boluses, and retains active insulin during battery changes. Active Insulin is displayed. NO Food boluses are not included in active insulin calculation, which may result in an accidental over-correction by the user.
Simple Bolus Calculation Calculating a bolus with minimal button pushes makes life easier and helps prevent errors. The Bolus WizardTM makes it easy to calculate a bolus. Minimal button pushes are required, and recommended bolus values are displayed to help avoid mistakes. Option to bolus remotely with a remote control (sold separately). YES Recommended bolus values are pre-populated. Bolus function requires use of Personal Diabetes Manager (PDM), so can not bolus if PDM is forgotten or misplaced.
Pediatric Friendly Features Ability to adapt the pump to fit the distinct needs of even the youngest users. No other pump offers a lower basal rate (0.025 units/hr) and the most precise bolus calculation (0.025 units) available for fine-tuned control. Only pump with a 300 units reservoir - good for higher insulin dosing populations. Many accessories are available to personalize the pump. NO A 0.025 units/hr basal rate and 0.025 units bolus increments are not available.
Convenient Insulin Delivery for People with Type 2 Diabetes Only the MiniMed® VEOTM is clinically proven to reduce A1c better than multiple daily shots for people with type 2 diabetes.12 A 300 units reservoir is offered to accommodate higher daily insulin requirements. Maximum bolus can be set up to 75 units. NO No 300 unit reservoir. Only a 200 unit reservoir is offered. Maximum bolus of 30 units.
Ease of Use Easy to navigate menus makes using the system or pump easy. The pump is easy to use with simple menus, a back button, step-by-step navigation, and minimal button pushing for simple tasks. In addition, pump screen has large fonts, easy to see icons & is easy to read in direct sunlight. LTD To set a basal rate, multiple steps are required including suspending the pump.
Convenient Software Sharing glucose patterns and insulin delivery with a healthcare provider can help to improve glucose control. Clinically proven Medtronic CareLink® Software has been shown to help lower A1c.11 CareLink® links from a patient’s home to the healthcare provider’s office allowing them to review patient information remotely and help make needed adjustments. PC and MAC compatible. LTD Some evidence that the use of the Omnipod software as part of a diabetes treatment regimen can help lower A1c. Software does not link to the healthcare provider’s office.
CGM: Customizable Alerts Customizable predictive alerts notify user of possible high and low glucose levels before they occur. Customize up to 8 different High and Low predictive alerts for different times of the day. NO N/A - No CGM available
CGM: Restored Glucose Readings If out of range of the receiver, automatic data storage minimizes loss of data. Automatically stores 40 minutes of missed glucose readings when out of range of the receiver. NO N/A - No CGM available
Blood Glucose Meter (BGM) with Wireless Capabilities An integrated BGM helps minimize insulin dosing errors by allowing BG readings to be sent wirelessly to the pump. Bayer Contour® Next Link meter sends BG readings to the pump wirelessly. Link up to 3 Contour® Next Link meters to the pump (home, office, school). Most accurate BG meter available (+/- 10% to lab accuracy).4 YES
Insulin Reservoir Size(s) Helps customize insulin delivery to each patient’s needs. 2 reservoir sizes are available: 180 units (1.8 mL) and 300 units (3.0 mL). LTD Only a 200 units reservoir size is available. Minimum fill of 85 units is required. Insulin delivery shuts off after 80 hours.
The Truth About Water Resistance All insulin pumps are water resistant at time of manufacturing. IPX7 – An IPX7 rating means they can usually withstand an accidental dunk or splash but should not be immersed in water. The insulin pump meets the water standard of 1 metre (approximately 3 feet) for 30 minutes.13 YES IPX8 – Pod portion only, Personal Diabetes Manager (PDM) is not waterproof.


1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of Type 1 diabetes. N Engl J Med. 2008;359:1464-1476.
2. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
3. User evaluations. Data on file, Medtronic MiniMed, Inc.
4. CONTOUR® NEXT LINK meter meets ±10% accuracy vs. laboratory method for blood glucose concentrations, specifically: 99.2% of results within ±10% for blood glucose concentrations ≥4.2 mmol/L, and 100% of results within ±0.56 mmol/L accuracy vs. laboratory method for blood glucose concentrations <4.2 mmol/L.
11. Corriveau EA, Durso PJ, Kaufman ED, et al. Effect of CareLink®, an internet based insulin pump monitoring system, on glycemic control in rural and urban children with type 1 diabetes mellitus. Pediatric Diabetes. 2008;9(Partii):360-366.
12. Reznik Y. Cohen O. Aronson R. et al, Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomized open-label controlled trial. The Lancet 2014; published online July 3. Source : http://www.medtronicdiabetes.com/treatment-and-products/insulin-pump-therapy-type-2
13. https://www.medtronic-diabetes.co.uk/customer-support/insulin-pumps/important-safety-information
MiniMed and Enlite are registered trademarks of Medtronic MiniMed, Inc. Veo, and Bolus Wizard are trademarks of Medtronic MiniMed, Inc. Medtronic CareLink and CareLink are registered trademarks of Medtronic, Inc.
14. Battelino T, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia DOI 10.1007/s00125-012-2708-9
15. Ly T. et al Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes A Randomized Clinical Trial JAMA. 2013;310(12):1240-1247
All other product names and trademarks are the pro perty of their respective owners.


Medtronic Canada
99 Hereford Street, Brampton, ON L6Y 0R3
1-866-444-4649
www.medtronicdiabetes.ca


Privacy statement | Terms of use